Overview:
Global Acetazolamide Market, By Application (Altitude Sickness, Drug-induced Edema, Epilepsy, Fluid Retention, Glaucoma, Heart Failure, and Seizures), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), By Formulation (Capsules, Injection, and Tablets), and by Region (North America, Africa, Asia Pacific, Middle East, Latin America, and Europe) and is approximated to have a market valuation of US$ 183.2 million in 2017 and is anticipated to manifest a CAGR of 4.8% over the forecast period of 2018-2026, as mentioned in a new report published by Coherent Market Insights.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2396
Market Drivers:
Acetazolamide is utilized for the prevention of excessive altitude contamination in multiple individuals, that’s characterized by headache, vomiting, nausea, and fatigue, though it also affects the lungs or the brain. For instance, according to the research published in June 2017 in Cochrane Journal, acetazolamide will be utilized in the treatment for the deterrence of acute high-altitude illness in daily doses of 250 to 750 mg. For the prevention of acute mountain sickness along with its side effects, acetazolamide is used with supplements such as dexamethasone.
In July 2018, Scientists at the University of Chicago examined acetazolamide, and posted it in the journal Science Translational Medicine, expressing that the altitude sickness drug, acetazolamide, allows overcoming opposition to chemotherapy medication temozolomide (TMZ). It is commonly used for gliomas therapy, even several patients respond negatively to the treatment. Along with the acetazolamide, scientists discovered elevated survival rates, among pre-clinical models of glioma. Based on the research, the use of acetazolamide mixed with TMZ displayed a 30 to 40% rise in animals. Application of acetazolamide might be used as an opportunity remedy answer for reducing resistance to chemotherapy inside the treatment of gliomas, which offers moneymaking growth possibilities for the drug inside the market quickly.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2396
Likewise, together with chronic simple (open-angle) glaucoma, secondary glaucoma, and acute mountain illness in climbers, acetazolamide has been indicated as the adjective remedy of edema because of congestive heart failure; drug-prompted edema; centrencephalic epilepsies.
Market Restraints:
The increasing prevalence of glaucoma and associated hazard elements which include diabetes, high myopia, eye surgery or injury, high blood strain, expanded utilization of corticosteroids, and own family history of glaucoma some of the worldwide population is expected to offer a conducive future boom for acetazolamide drug manufacturers. A sustained-release pill of Acetazolamide taken a day offers a large strain-reducing impact that lasts for a day. Acetazolamide therapy aids in deducing eye pressure, which prevents eye injury. Acetazolamide works by stopping the motion of an enzyme known as carbonic anhydrase thereby, decreasing the quantity of fluid secreted within the front a part of the attention, thus reducing eye stress. For instance, in 2014, the Journal of Ophthalmology published a paper, based on that, in 2013, almost 64.3 patients of age 40 to 80, were diagnosed with glaucoma. In 2020, that number rises to 76 million followed by 2040, it will be up to 111.8 million.
Based on the paper published in 2017 by the International Agency for the Prevention of Blindness, glaucoma is the second main purpose of blindness and the ultimate reason for irreversible blindness globally. Along with primary angle-closure glaucoma (PACG) is the maximum commonplace in South-East Asia whilst number one open-perspective glaucoma (POAG) is located among white Caucasians and individuals of Africa.
Key Players:
- Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
- X-GEN Pharmaceuticals
Inc. - Novast Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
- Strides Shasun Limited
- Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
- Lannett Company
Inc. - Nostrum Laboratories Inc.
- Heritage Pharmaceuticals Inc.
Direct Purchase This Report with Access of full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2396
Reasons to Purchase This Report
• Current and future of Acetazolamide Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Epidemiology
- Key Developments
- Drug Approvals and Launches
- Strategic Collaborations & Acquisitions
- Regulatory Scenario
- Pipeline Analysis
- Market Dynamics
- Global Acetazolamide Market, By Formulation, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Acetazolamide Market, By Application, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Drug indicted Edema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Altitude Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Fluid Retention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Acetazolamide Market, By Distribution Channel, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Acetazolamide Market, By Region, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2026
- North America
- Market Size and Forecast, By Formulation, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- North Africa
- Central Africa
- South Africa
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/acetazolamide-market-to-surpass-us-2790-million-by-2026-1231
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837